ReviewPharmaceutics2025

Reprogramming Atherosclerosis: Precision Drug Delivery, Nanomedicine, and Immune-Targeted Therapies for Cardiovascular Risk Reduction.

Paschalis Karakasis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.